These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9631309)

  • 1. The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain.
    Gomollón F; Ducóns JA; Gimeno L; Fuentes J; García S; Vera J; Montoro M
    Helicobacter; 1998 Jun; 3(2):110-4. PubMed ID: 9631309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
    Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
    Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
    Am J Gastroenterol; 2003 Mar; 98(3):562-7. PubMed ID: 12650788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
    Nie Y; Li Y; Wu H; Sha W; Du H; Dai S; Wang H; Li Q
    Helicobacter; 1999 Jun; 4(2):128-34. PubMed ID: 10382127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
    Sotudehmanesh R; Malekzadeh R; Fazel A; Massarrat S; Ziad-Alizadeh B; Eshraghian MR
    J Gastroenterol Hepatol; 2001 Mar; 16(3):264-8. PubMed ID: 11339416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial.
    Xie Y; Pan X; Li Y; Wang H; Du Y; Xu J; Wang J; Zeng Z; Chen Y; Zhang G; Wu K; Liu D; Lv N
    J Antimicrob Chemother; 2018 Jun; 73(6):1681-1687. PubMed ID: 29596646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.
    Emami MH; Saberfiroozi MM; Arj A; Taghavi AR; Bagheri-Lankarani K; Dehbashi N; Fattahi MR; Alizadeh M; Kaviani MJ; Bahri-Najafi R; Geramizadeh B; Esmaeili A
    World J Gastroenterol; 2006 Oct; 12(39):6310-5. PubMed ID: 17072954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
    Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
    Hosking SW; Ling TK; Chung SC; Yung MY; Cheng AF; Sung JJ; Li AK
    Lancet; 1994 Feb; 343(8896):508-10. PubMed ID: 7906759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.
    De Boer WA; Driessen WM; Tytgat GN
    Aliment Pharmacol Ther; 1995 Dec; 9(6):633-8. PubMed ID: 8824650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
    de Boer WA; Driessen WM; Jansz AR; Tytgat GN
    Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1189-94. PubMed ID: 8789310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
    Isakov V; Domareva I; Koudryavtseva L; Maev I; Ganskaya Z
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1277-82. PubMed ID: 12144577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
    de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
    Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
    de Boer SY; v d Meeberg PC; Siem H; de Boer WA
    Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
    Graham DY; Saeed MA; Hoffman J; El-Zimaity HM; Kwon DH; Osato MS
    Aliment Pharmacol Ther; 2001 Apr; 15(4):513-8. PubMed ID: 11284780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
    Mantzaris GJ; Petraki K; Archavlis E; Amberiadis P; Christoforidis P; Kourtessas D; Chiotakakou E; Triantafyllou G
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1237-43. PubMed ID: 12439119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
    Marko D; Calvet X; Ducons J; Guardiola J; Tito L; Bory F;
    Helicobacter; 2005 Feb; 10(1):22-32. PubMed ID: 15691312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.